Immunotherapy as a Promising Option for the Treatment of Advanced Chordoma: A Systemic Review

Immunotherapy as a Promising Option for the Treatment of Advanced Chordoma: A Systemic Review

Objective: To summarize the function and efficacy of immunotherapy as an adjunctive therapy in the treatment of advanced chordoma. Methods: Literature search was conducted by two reviewers independently. Case reports, case series and clinical trials of immunotherapy for chordoma were retrieved syste...

Full description

Bibliographic Details
Main Authors:	Xiang Wang, Zhaoyu Chen, Bo Li, Jiefu Fan, Wei Xu, Jianru Xiao
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Cancers
Subjects:	chordoma immunotherapy vaccines immune checkpoint inhibitor combination
Online Access:	https://www.mdpi.com/2072-6694/15/1/264

Similar Items

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies
by: Jiuhui Xu, et al.
Published: (2023-09-01)

First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies
by: Denis Migliorini, et al.
Published: (2017-08-01)

Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence
by: Jeffrey I. Traylor, et al.
Published: (2021-05-01)

A case of refractory chordoma of the clivus with a review of therapeutic targets
by: Gogo-ogute E. Ibodeng, et al.
Published: (2022-12-01)

Immunotherapy in Advanced Biliary Tract Cancers
by: Alice Boilève, et al.
Published: (2021-03-01)

Poorly differentiated chordoma
by: Li Yang, et al.
Published: (2022-06-01)

Immunotherapy for glioblastoma: the promise of combination strategies
by: Mathilde Bausart, et al.
Published: (2022-01-01)

Chordomas, malignant spinal tumors
by: Niki Adrian Calina, et al.
Published: (2016-03-01)

Translational Windows in Chordoma: A Target Appraisal
by: Samantha E. Hoffman, et al.
Published: (2020-07-01)

Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review
by: Shujing Liang, et al.
Published: (2021-07-01)

Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining
by: Bharat Rekhi, et al.
Published: (2017-01-01)

Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach
by: Chang-Gon Kim, et al.
Published: (2021-07-01)

Advances in Immunotherapy for Malignant Pleural Mesothelioma
by: Yujia CHI, et al.
Published: (2022-04-01)

Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
by: Chang-Myung Oh, et al.
Published: (2020-10-01)

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
by: T. Anders Olsen, et al.
Published: (2022-03-01)

VISTA: A Promising Target for Cancer Immunotherapy?
by: Tagliamento M, et al.
Published: (2021-06-01)

B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma
by: Cheng Long, et al.
Published: (2021-11-01)

Perineal chordoma cutis, a rare localization for a rare pathology: a case report and consideration of the literature
by: Chennoufi Mehdi, et al.
Published: (2020-05-01)

Future prospects for cancer immunotherapy - Strategies for ineffective cancers
by: Satoshi Wada, et al.
Published: (2022-01-01)

Chordoma: study of five cases
by: B Sigdel, et al.
Published: (2012-09-01)

Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
by: Paolo A. Ascierto, et al.
Published: (2022-06-01)

Surgical management of a case of C2 vertebral chordoma via staged anterior and posterior approach
by: Nigil S Palliyil, et al.
Published: (2020-01-01)

Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd–3rd, 2020, Italy)
by: Paolo A. Ascierto, et al.
Published: (2021-06-01)

Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th–December 1st, 2022)
by: Paolo A. Ascierto, et al.
Published: (2023-07-01)

Advances in Immunotherapy for Adult Glioblastoma
by: Chirayu R. Chokshi, et al.
Published: (2021-07-01)

Recent Advances in Immunotherapy for Hepatocellular Carcinoma
by: Shigeharu Nakano, et al.
Published: (2020-03-01)

Distribution of Age and Location of Chordoma in 39 Cases and Review of Treatment Options
by: Shahab Kamali Ardekani, et al.
Published: (2012-02-01)

Distribution of Age and Location of Chordoma in 39 Cases and Review of Treatment Options
by: Alireza Khoshnevisan, et al.
Published: (2012-02-01)

Thoracic Chordoma Misdiagnosed as Primary Adenocarcinoma of the Mediastinum
by: Seung Keun Yoon, et al.
Published: (2021-04-01)

Extensive sphenoid chordoma mimicking a prolactinoma
by: Mounira El Euch, et al.
Published: (2019-06-01)

A Promising Treatment Strategy for Lung Cancer: A Combination of Radiotherapy and Immunotherapy
by: Yuhei Miyasaka, et al.
Published: (2021-12-01)

Intestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy
by: Zhujiang Dai, et al.
Published: (2022-09-01)

Developments in Immunotherapy for Advanced Non-small Cell Lung Cancer
by: Haoyang LI, et al.
Published: (2021-02-01)

Current Advancements and Future Perspectives of Immunotherapy in Breast Cancer Treatment
by: Maria Vasileiou, et al.
Published: (2023-05-01)

Preclinical and clinical studies of immunotherapy for the treatment of cholangiocarcinomaKey points
by: Xinjun Lu, et al.
Published: (2023-07-01)

Novel immunotherapy in metastatic renal cell carcinoma
by: Yang Hyun Cho, et al.
Published: (2017-07-01)

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
by: Mai F. Tolba, et al.
Published: (2021-11-01)

The role of biomarkers in personalized immunotherapy
by: Kamya Sankar, et al.
Published: (2022-05-01)

The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives
by: Robert J. Walsh, et al.
Published: (2021-09-01)

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
by: Lei Yu, et al.
Published: (2022-10-01)